To study the effect of Shivagutika medicine in pre- Diabetes patients

THE EVALUATION OF A POLYHERBAL FORMULA SHIVAGUTIKA FOR ITS ANTI INFLAMMATORY EFFECT AN IN VITRO AND AN EXTENDED CLINICAL PILOT STUDY. - nil

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088651

Enrollment

Registered

2025-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Cases of prediabetes on the basis of the laboratory investigation between the age group 30 to 40 years of both sexes. HbA1C between 5.7 to 6.4 mg/dL. FBS levels falling between- 100 to120 mg/dL PPBS levels falling between- 140 to 199 mg/dL Onset less than 6 months. BMI Above 21. A Positive family history of type 2 DM. Higher than normal values of lipid profile values.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Reduction in the symptoms of pre diabetes.Timepoint: Baseline, 90th day/12 weeks	—

Secondary

Measure	Time frame
Reduction in HbA1c, PPBS Values.Timepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Naresh Kore

Parul Institute of Ayurveda

Naresh.kore86275@paruluniversity.ac.in8275174623

Outcome results